Top Story

FDA grants orphan drug designation to veltuzumab for ITP

August 4, 2015

The FDA granted orphan drug designation to veltuzumab — a humanized anti-CD20 antibody — for the treatment of patients with immune thrombocytopenia, according to a press release from the drug’s manufacturer.

Results of a phase 1 study showed low-dose, single-agent veltuzumab (Immunomedics) demonstrated an objective response rate of 55% in 38 response-assessable patients with relapsed immune thrombocytopenia (ITP). Eleven patients (29%) experienced a complete response.

In the Journals

Urine biomarkers accurately identify early-stage pancreatic cancer

August 4, 2015
Researchers have developed a three-biomarker panel that can detect early-stage pancreatic ductal adenocarcinoma through urine analysis, which could lead to a noninvasive…
Rita F. Redberg, MD, MSc In the Journals

Surrogate endpoints may not predict OS in oncology clinical trials

August 4, 2015
A majority of trial-level validation studies of surrogate endpoints demonstrated little correlation with survival rates, according to a systematic review of trial-level…
Hatem A. Azim, Jr., MD In the Journals

Assisted reproduction feasible for women with breast cancer history

August 4, 2015
Women with a history of breast cancer can utilize assisted reproductive technology to become pregnant without any detriment to their cancer outcome, according to study…
David J. Adelstein, MD, FACP Meeting News Coverage

Top Takeaways from ASCO: Neck dissection in head and neck cancer

August 3, 2015
CHICAGO – The decision-making process used by physicians to determine whether a neck dissection is appropriate in patients with head and neck cancer may change as…
More News Headlines »
Tailored Therapies for Myelodysplastic Syndromes

Tailored Therapies for Myelodysplastic Syndromes

This activity is supported by an educational grant from Celgene Corporation.

Myelodysplastic syndromes (MDS) represent a group of myeloid clonal hemopathies with heterogeneous clinical…
More »
Meeting News Coverage Video
VIDEO: 'Care paths' may help manage rising cancer costs

VIDEO: 'Care paths' may help manage rising cancer costs

June 19, 2015
CHICAGO — Brian Bolwell, MD, chairman of Taussig Cancer Institute at Cleveland Clinic, discusses an abstract on…
More »
Hematology Oncology Case Consults

The Patient with Multiple Myeloma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with multiple myeloma.
More »